ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 735372 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 735372; 2) Community: the network communities that were significantly associated with the response to NSC 735372; 3) Molecule: the relationships between components within communities and NSC 735372; 4) MDR: the compounds that were significantly associated with the NSC 735372.

NSC Compound Enrichment Correlation
NSC 746513 5-Triazol-2-yl-methyl-2-[2?,(2??-chlorophenyl)-thiazolidin-4?-one-3?-yl]-1,3,4-oxadiazole 0.0462077035966084 0.1551811
NSC 748904 [(20S)-20-(N,N-dimethylamino)-5a-preg-3a-aminal], N-formylchonemorphine 0.0462077035966084 0.20640285
NSC 749862 3-[2-(4-methoxyphenyl)-1,3-thiazol-4-yl]-1-methyl-1H-pyrrolo[2,3-b]pyridine 0.0462077035966084 0.027188466
NSC 88915 Null 0.0462077035966084 0.39371362
NSC 92618 Dichlorodipropyltin 0.0462077035966084 0.097103339
NSC 93135 OXYACANTHINE 0.0462077035966084 0.20090682
NSC 1390 Allopurinol 0.0462077035966088 0.0059422905
NSC 17 4-AMINO-3-PENTADECYLPHENOL 0.0462077035966088 0.16363568
NSC 179074 Lead, bis[(2-cyanoethyl)cyclohexylcarbamodithioato-S,S']-, (T-4)- 0.0462077035966088 0.279468
NSC 179940 Benzofurazan, 4-(4-methyl-1-piperazinyl)-7-nitro-, 3-oxide 0.0462077035966088 0.32708587
Total:125  Current:114    [First] [Prev] [Next] [Last]